ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-11C18348
Home | Market Reports | Health| Health Conditions
Global Extracorporeal Membrane Oxygenation Therapy ECMO Market Research Report 2024
BUY CHAPTERS

Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2026

Code: QYRE-Auto-11C18348
Report
2026-02-26
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Getinge
Terumo
Nipro
Medtronic Inc
LivaNova
Xenios AG
ALung Technologies
EUROSETS S.r.l.
OriGen Biomedical
MicroPort Scientific

Extracorporeal Membrane Oxygenation Therapy (ECMO) Market

The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Extracorporeal Membrane Oxygenation Therapy (ECMO) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
The North American market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO) include GETINGE, Terumo, NIPRO, Medtronic, LivaNova, XENIOS AG, ALung Technologies, EUROSETS, OriGen Biomedical, MicroPort Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Therapy (ECMO). The Extracorporeal Membrane Oxygenation Therapy (ECMO) market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracorporeal Membrane Oxygenation Therapy (ECMO) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Report

Report Metric Details
Report Name Extracorporeal Membrane Oxygenation Therapy (ECMO) Market
Segment by Type
  • Veinous (VA)
  • Venous (VV)
  • Arteriovenous (AV)
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GETINGE, Terumo, NIPRO, Medtronic, LivaNova, XENIOS AG, ALung Technologies, EUROSETS, OriGen Biomedical, MicroPort Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Extracorporeal Membrane Oxygenation Therapy (ECMO) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Extracorporeal Membrane Oxygenation Therapy (ECMO) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market report?

Ans: The main players in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market are GETINGE, Terumo, NIPRO, Medtronic, LivaNova, XENIOS AG, ALung Technologies, EUROSETS, OriGen Biomedical, MicroPort Scientific

What are the Application segmentation covered in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market report?

Ans: The Applications covered in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market report?

Ans: The Types covered in the Extracorporeal Membrane Oxygenation Therapy (ECMO) Market report are Veinous (VA), Venous (VV), Arteriovenous (AV)

1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Overview
1.1 Product Definition
1.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type
1.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Type: 2025 vs 2032
1.2.2 Veinous (VA)
1.2.3 Venous (VV)
1.2.4 Arteriovenous (AV)
1.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application
1.3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size Estimates and Forecasts
1.4.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2021–2032
1.4.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2021–2032
1.4.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competition by Manufacturers
2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Extracorporeal Membrane Oxygenation Therapy (ECMO), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Product Types and Applications
2.7 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Date of Entry into the Industry
2.8 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competitive Situation and Trends
2.8.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Players Market Share by Revenue
2.8.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Scenario by Region
3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2021–2032
3.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2021–2026
3.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2027–2032
3.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2021–2032
3.3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2021–2026
3.3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2027–2032
3.4 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.4.1 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2021–2032)
3.4.3 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.5.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2021–2032)
3.5.3 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Region
3.6.1 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2021–2032)
3.6.3 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.7.1 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2021–2032)
3.7.3 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2021–2032)
4.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2021–2026)
4.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2027–2032)
4.1.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2021–2032)
4.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2021–2032)
4.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2021–2026)
4.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2027–2032)
4.2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2021–2032)
4.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2021–2032)
5.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2021–2026)
5.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2027–2032)
5.1.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2021–2032)
5.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2021–2032)
5.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2021–2026)
5.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2027–2032)
5.2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2021–2032)
5.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GETINGE
6.1.1 GETINGE Company Information
6.1.2 GETINGE Description and Business Overview
6.1.3 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.1.5 GETINGE Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 NIPRO
6.3.1 NIPRO Company Information
6.3.2 NIPRO Description and Business Overview
6.3.3 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.3.5 NIPRO Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 LivaNova
6.5.1 LivaNova Company Information
6.5.2 LivaNova Description and Business Overview
6.5.3 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.5.5 LivaNova Recent Developments/Updates
6.6 XENIOS AG
6.6.1 XENIOS AG Company Information
6.6.2 XENIOS AG Description and Business Overview
6.6.3 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.6.5 XENIOS AG Recent Developments/Updates
6.7 ALung Technologies
6.7.1 ALung Technologies Company Information
6.7.2 ALung Technologies Description and Business Overview
6.7.3 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.7.5 ALung Technologies Recent Developments/Updates
6.8 EUROSETS
6.8.1 EUROSETS Company Information
6.8.2 EUROSETS Description and Business Overview
6.8.3 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.8.5 EUROSETS Recent Developments/Updates
6.9 OriGen Biomedical
6.9.1 OriGen Biomedical Company Information
6.9.2 OriGen Biomedical Description and Business Overview
6.9.3 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.9.5 OriGen Biomedical Recent Developments/Updates
6.10 MicroPort Scientific
6.10.1 MicroPort Scientific Company Information
6.10.2 MicroPort Scientific Description and Business Overview
6.10.3 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.10.5 MicroPort Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Chain Analysis
7.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Production Mode & Process Analysis
7.4 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales and Marketing
7.4.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Channels
7.4.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors
7.5 Extracorporeal Membrane Oxygenation Therapy (ECMO) Customer Analysis
8 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Dynamics
8.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Trends
8.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Drivers
8.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Challenges
8.4 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Getinge
Terumo
Nipro
Medtronic Inc
LivaNova
Xenios AG
ALung Technologies
EUROSETS S.r.l.
OriGen Biomedical
MicroPort Scientific
List of Tables
 Table 1. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Extracorporeal Membrane Oxygenation Therapy (ECMO), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Product Types and Applications
 Table 12. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (Units), 2021–2026
 Table 18. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2021–2026)
 Table 19. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (Units), 2027–2032
 Table 20. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2027–2032)
 Table 21. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2021–2026)
 Table 23. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2027–2032)
 Table 25. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2021–2026
 Table 27. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2027–2032
 Table 28. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2021–2026
 Table 32. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2027–2032
 Table 33. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2021–2026
 Table 42. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2027–2032
 Table 43. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Type (2021–2026)
 Table 51. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Type (2027–2032)
 Table 52. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2021–2026)
 Table 53. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2027–2032)
 Table 54. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2021–2026)
 Table 57. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2027–2032)
 Table 58. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Application (2021–2026)
 Table 61. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Application (2027–2032)
 Table 62. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2021–2026)
 Table 63. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2027–2032)
 Table 64. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2021–2026)
 Table 67. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2027–2032)
 Table 68. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2027–2032)
 Table 70. GETINGE Company Information
 Table 71. GETINGE Description and Business Overview
 Table 72. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 74. GETINGE Recent Developments/Updates
 Table 75. Terumo Company Information
 Table 76. Terumo Description and Business Overview
 Table 77. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 79. Terumo Recent Developments/Updates
 Table 80. NIPRO Company Information
 Table 81. NIPRO Description and Business Overview
 Table 82. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 84. NIPRO Recent Developments/Updates
 Table 85. Medtronic Company Information
 Table 86. Medtronic Description and Business Overview
 Table 87. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 89. Medtronic Recent Developments/Updates
 Table 90. LivaNova Company Information
 Table 91. LivaNova Description and Business Overview
 Table 92. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 94. LivaNova Recent Developments/Updates
 Table 95. XENIOS AG Company Information
 Table 96. XENIOS AG Description and Business Overview
 Table 97. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 99. XENIOS AG Recent Developments/Updates
 Table 100. ALung Technologies Company Information
 Table 101. ALung Technologies Description and Business Overview
 Table 102. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 104. ALung Technologies Recent Developments/Updates
 Table 105. EUROSETS Company Information
 Table 106. EUROSETS Description and Business Overview
 Table 107. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 109. EUROSETS Recent Developments/Updates
 Table 110. OriGen Biomedical Company Information
 Table 111. OriGen Biomedical Description and Business Overview
 Table 112. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 114. OriGen Biomedical Recent Developments/Updates
 Table 115. MicroPort Scientific Company Information
 Table 116. MicroPort Scientific Description and Business Overview
 Table 117. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
 Table 119. MicroPort Scientific Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors List
 Table 123. Extracorporeal Membrane Oxygenation Therapy (ECMO) Customers List
 Table 124. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Trends
 Table 125. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Drivers
 Table 126. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Challenges
 Table 127. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Figure 2. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Type: 2025 & 2032
 Figure 4. Veinous (VA) Product Picture
 Figure 5. Venous (VV) Product Picture
 Figure 6. Arteriovenous (AV) Product Picture
 Figure 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size (US$ Million), 2021–2032
 Figure 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), 2021–2032
 Figure 15. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price (US$/Unit), 2021–2032
 Figure 16. Extracorporeal Membrane Oxygenation Therapy (ECMO) Report Years Considered
 Figure 17. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Share by Manufacturers in 2025
 Figure 18. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Players: Market Share by Revenue in Extracorporeal Membrane Oxygenation Therapy (ECMO) in 2025
 Figure 20. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2021–2032)
 Figure 23. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2021–2032)
 Figure 24. United States Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2021–2032)
 Figure 27. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2021–2032)
 Figure 35. China Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type (2021–2032)
 Figure 55. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application (2021–2032)
 Figure 58. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2021–2032)
 Figure 59. Extracorporeal Membrane Oxygenation Therapy (ECMO) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Cardiopulmonary Assisted Membrane Oxygenator Market Research Report 2024
Global Extracorporeal Membrane Oxygenation ECMO Service Market Research Report 2024
Global Extracorporeal Membrane Oxygenators ECMO Market Insights Forecast to 2030
Global Medical ECMO System Market Research Report 2024
Global Extracorporeal Membrane Oxygenation ECMO Machine Market Research Report 2024
Global Extracorporeal Membrane Oxygenation ECMO Systems Market Research Report 2025
Global ECMO Devices Market Research Report 2024
Global ECMO Machine Market Research Report 2024
Global Cardiopulmonary Assist System ECMO Market Research Report 2024
Extracorporeal Membrane Oxygenation ECMO Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ECMO Oxygenator Market Research Report 2025
Extra Corporeal Membrane Oxygenation ECMO System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Extracorporeal Membrane Oxygenation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veno Arterial ECMO System Market Research Report 2025
Global Veno Artrial ECMO System Market Research Report 2024
Extracorporeal Membrane Oxygenation ECMO Outsourcing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Membrane Oxygenator Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global ECCO₂R Devices Market Research Report 2024
Global Veno Venous Extracorporeal Life Support VV ECLS Devices Market Research Report 2024
Global Extracorporeal CO₂ Removal ECCO₂R System Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions